Variant report
Variant | nsv512323 |
---|---|
Chromosome Location | chr13:65341495-65344616 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:0)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
No data |
No data |
No data |
No data |
No data |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs190578254 | chr13:65341503-65341504 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
2 | rs561512995 | chr13:65341528-65341529 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
3 | rs12870496 | chr13:65341591-65341592 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
4 | rs550317819 | chr13:65341592-65341593 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
5 | rs56976038 | chr13:65341624-65341625 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
6 | rs139006505 | chr13:65341639-65341640 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
7 | rs570212809 | chr13:65341663-65341664 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
8 | rs562189533 | chr13:65341742-65341743 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
9 | rs143744104 | chr13:65341746-65341747 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
10 | rs529491633 | chr13:65341790-65341791 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
11 | rs147208056 | chr13:65341807-65341808 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
12 | rs569559588 | chr13:65341863-65341864 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
13 | rs180948399 | chr13:65341913-65341914 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
14 | rs140507691 | chr13:65341931-65341932 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
15 | rs555667196 | chr13:65341943-65341944 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
16 | rs149296426 | chr13:65341951-65341952 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
17 | rs535020716 | chr13:65341957-65341958 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
18 | rs11839517 | chr13:65342008-65342009 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
19 | rs200488255 | chr13:65342012-65342013 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
20 | rs149546880 | chr13:65342037-65342038 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
21 | rs578138525 | chr13:65342048-65342049 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
22 | rs143122844 | chr13:65342071-65342072 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
23 | rs543981449 | chr13:65342093-65342094 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
24 | rs113551902 | chr13:65342096-65342097 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
25 | rs563851893 | chr13:65342106-65342107 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
26 | rs113947362 | chr13:65342134-65342135 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
27 | rs112637787 | chr13:65342139-65342140 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
28 | rs566372907 | chr13:65342161-65342162 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
29 | rs540128517 | chr13:65342170-65342171 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
30 | rs542920568 | chr13:65342171-65342172 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
31 | rs9598838 | chr13:65342217-65342218 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
32 | rs144514658 | chr13:65342225-65342226 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
33 | rs148424425 | chr13:65342238-65342239 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
34 | rs546995037 | chr13:65342256-65342257 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
35 | rs563776784 | chr13:65342300-65342301 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
36 | rs371177506 | chr13:65342320-65342321 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
37 | rs142526237 | chr13:65342356-65342357 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
38 | rs146430530 | chr13:65342418-65342419 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
39 | rs569733969 | chr13:65342434-65342435 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
40 | rs11617114 | chr13:65342461-65342462 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
41 | rs548977994 | chr13:65342474-65342475 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
42 | rs139795872 | chr13:65342494-65342495 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
43 | rs534652052 | chr13:65342512-65342513 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
44 | rs558182434 | chr13:65342547-65342548 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
45 | rs571696726 | chr13:65342653-65342654 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
46 | rs143912617 | chr13:65342733-65342734 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
47 | rs146864446 | chr13:65342752-65342753 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
48 | rs185073812 | chr13:65342824-65342825 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
49 | rs543211549 | chr13:65342909-65342910 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
50 | rs190272986 | chr13:65342910-65342911 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Esophageal squamous carcinoma | 21637470 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
HIV/AIDS | 22032296 | CNVD |
Prostate cancer | 16705090 | CNVD |
High-proliferative meningiomas | 17937814 | CNVD |
Thoracic aortic aneurysm | 21092924 | CNVD |
Intellectual disability | 22102821 | CNVD |
Cancer | 20164919 | CNVD |
Autism | 22495311 | CNVD |
Chordoma | 21602918 | CNVD |
Bladder cancer | 21949216 | CNVD |
Acute myeloid leukemia | 16864856 | CNVD |
Burkitt''s lymphoma | 18698080 | CNVD |
Cancer | 21637783 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Chronic lymphocytic leukemia | 21518781 | CNVD |
colon cancer | 17210682 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Colorectal cancer | 20709793 | CNVD |
Astrocytoma | 17387387 | CNVD |
Breast cancer | 21264507 | CNVD |
Glioblastoma multiforme | 19960244 | CNVD |
Glioblastoma multiforme | 17387387 | CNVD |
Hepatocellular carcinoma | 22174799 | CNVD |
Ovarian cancer | 20844748 | CNVD |
Colorectal cancer | 19359472 | CNVD |
Intracranial aneurysm | 19064780 | CNVD |
Breast cancer | 19287154 | CNVD |
Acute myeloid leukemia | 18379011 | CNVD |
Human rectal carcinomas | 16397240 | CNVD |
Olfactory neuroblastoma | 18408657 | CNVD |
Multiple myeloma | 17077331 | CNVD |
Ependymoma | 16718352 | CNVD |
Oral squamous cell carcinoma | 17134496 | CNVD |
Colorectal cancer | 16272173 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Squamous cell cancer | 20885788 | CNVD |
Myeloproliferative neoplasm | 20015882 | CNVD |
Thyroid cancer | 19087340 | CNVD |
Gastrointestinal stromal cancer | 16982739 | CNVD |
Breast cancer | 16608533 | CNVD |
Neuroblastoma | 18923191 | CNVD |
Ovarian cancer | 22174824 | CNVD |
Breast cancer | 17133270 | CNVD |
Myoepithelioma | 18604193 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Acute lymphoblastic leukemia | 21098271 | CNVD |
Prostate cancer | 16573809 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Paraganglioma | 21461997 | CNVD |
Pheochromocytoma | 21461997 | CNVD |
Acute lymphoblastic leukemia | 17690704 | CNVD |
Prostate cancer | 17245344 | CNVD |
Prostate cancer | 18632612 | CNVD |
Colorectal cancer | 21586687 | CNVD |
Small bowel adenocarcinoma | 21586687 | CNVD |
Retinoblastoma | 19183342 | CNVD |
Developmental delay | 21147756 | CNVD |
Melanoma | 18172304 | CNVD |
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Acute lymphoblastic leukemia | 22237106 | CNVD |
Merkel cell carcinoma | 19020549 | CNVD |
Basal cell lymphoma | 17053054 | CNVD |
Endometrioid adenocarcinoma | 16974079 | CNVD |
Non-syndromic sensorineural hearing loss | 18496225 | CNVD |
lymphocytic leukemia | 21291569 | CNVD |
Multiple myeloma | 17550852 | CNVD |
Breast cancer | 21858162 | CNVD |
Glioblastoma multiforme | 21922591 | CNVD |
Metanephric adenoma | 20802469 | CNVD |
High-grade prostatic intraepithelial neoplasia | 16573809 | CNVD |
Gastric cancer | 17908304 | CNVD |
Glioblastoma multiforme | 21750150 | CNVD |
Breast cancer | 17603634 | CNVD |
Cancer | 21183584 | CNVD |
Breast cancer | 17393978 | CNVD |
Splenic marginal zone lymphoma | 18492102 | CNVD |
Liposarcoma | 21253554 | CNVD |
Gastrointestinal stromal cancer | 20818650 | CNVD |
head and neck squamous cell carcinoma | 17671120 | CNVD |
Colorectal cancer | 16774939 | CNVD |
Adenoid cystic carcinoma | 17372589 | CNVD |
abnormal development | 18461090 | CNVD |
Acute promyelocytic leukemia | 19109227 | CNVD |
Chronic lymphocytic leukemia | 20421269 | CNVD |
Acute lymphoblastic leukemia | 21980252 | CNVD |
Acute myeloid leukemia | 20729466 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Lung cancer | 18438408 | CNVD |
Non-syndromic sensorineural hearing loss | 20606397 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr13:65340000-65341800 | Enhancers | HUVEC | blood vessel |
2 | chr13:65340800-65341600 | Enhancers | iPS-18 Cell Line | embryonic stem cell |
3 | chr13:65340800-65341800 | Enhancers | HUES64 Cell Line | embryonic stem cell |
4 | chr13:65341000-65341600 | Enhancers | HUES48 Cell Line | embryonic stem cell |
5 | chr13:65341200-65341600 | Enhancers | ES-I3 Cell Line | embryonic stem cell |
6 | chr13:65341200-65341600 | Enhancers | H1 Cell Line | embryonic stem cell |
7 | chr13:65341200-65341600 | Enhancers | iPS-20b Cell Line | embryonic stem cell |
8 | chr13:65341800-65343400 | Weak transcription | HUVEC | blood vessel |
9 | chr13:65343400-65344200 | Enhancers | HUVEC | blood vessel |